Cansino Biologics Inc Cash Flow Reinvestment Rate
Cansino Biologics Inc cash flow reinvestment rate. Cansino Biologics Inc (688185) has a Cash Flow Reinvestment Rate of 1.45x as of September 2025, reinvesting CN¥44.23 Million (capex CN¥44.23 Million ) from operating cash flow of CN¥30.53 Million. See 688185 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cansino Biologics Inc (2021–2025)
Cash flow reinvestment rate of Cansino Biologics Inc from 2021 to 2025. Historical reinvestment intensity for Cansino Biologics Inc across 2 annual periods. Explore cash flow to debt ratio of Cansino Biologics Inc to assess how comfortably operating cash covers total debt obligations.
Cansino Biologics Inc Cash Flow Reinvestment Rate by Year (2021–2025)
Cansino Biologics Inc cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for Cansino Biologics Inc. For the full cash flow conversion analysis, see 688185 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 10.78x | CN¥839.60 Million | CN¥77.86 Million | CN¥243.90 Million | ▲ +733.6% |
| 2021 | 1.29x | CN¥2.61 Billion | CN¥2.01 Billion | CN¥1.20 Billion | — |